ClinicalTrials.gov
public full text
Public Domain
Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis
A multicenter, randomized, single-blind, parallel-controlled clinical study to evaluate the efficacy and safety of boroda supramolecular active zinc in the treatment of scalp psoriasis. Main objective:：Compare the efficacy of boroda supramolecular active zinc and capotetriol liniment in the treatment of scalp psoriasis Secondary objective: To observe the safety of boroda supramolecular active zinc in the treatment of subjects with scalp psoriasis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease#1114912
- Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis#850619
- Efficacy of Zinc in the Treatment of Pneumonia#981453
- Zinc Supplementation Improves Cardiovascular Morbidity in Patients With Diabetes Mellitus#1295336
- The Effect of Oral Zinc Supplementation on Thiol Oxido-reductive Index#1351208
Record · ID 1431882
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive